These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Robustness analysis of the detailed kinetic model of an ErbB signaling network by using dynamic sensitivity. Masunaga H; Sugimoto Y; Magi S; Itasaki R; Okada-Hatakeyama M; Kurata H PLoS One; 2017; 12(5):e0178250. PubMed ID: 28542548 [TBL] [Abstract][Full Text] [Related]
25. Reduction of mathematical models of signal transduction networks: simulation-based approach applied to EGF receptor signalling. Conzelmann H; Saez-Rodriguez J; Sauter T; Bullinger E; Allgöwer F; Gilles ED Syst Biol (Stevenage); 2004 Jun; 1(1):159-69. PubMed ID: 17052126 [TBL] [Abstract][Full Text] [Related]
26. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054 [TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. Beerli RR; Hynes NE J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392 [TBL] [Abstract][Full Text] [Related]
28. The EGF receptor as central transducer of heterologous signalling systems. Zwick E; Hackel PO; Prenzel N; Ullrich A Trends Pharmacol Sci; 1999 Oct; 20(10):408-12. PubMed ID: 10577253 [TBL] [Abstract][Full Text] [Related]
29. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723 [TBL] [Abstract][Full Text] [Related]
30. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. Yamanaka Y Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773 [TBL] [Abstract][Full Text] [Related]
31. EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain. Jones SM; Foreman SK; Shank BB; Kurten RC Am J Physiol Cell Physiol; 2002 Mar; 282(3):C420-33. PubMed ID: 11832327 [TBL] [Abstract][Full Text] [Related]
33. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3. Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370 [TBL] [Abstract][Full Text] [Related]
34. Lateral propagation of EGF signaling after local stimulation is dependent on receptor density. Sawano A; Takayama S; Matsuda M; Miyawaki A Dev Cell; 2002 Aug; 3(2):245-57. PubMed ID: 12194855 [TBL] [Abstract][Full Text] [Related]
36. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046 [TBL] [Abstract][Full Text] [Related]
37. Multiple positive and negative regulators of signaling by the EGF-receptor. Moghal N; Sternberg PW Curr Opin Cell Biol; 1999 Apr; 11(2):190-6. PubMed ID: 10209155 [TBL] [Abstract][Full Text] [Related]
38. Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. Ferguson KM; Darling PJ; Mohan MJ; Macatee TL; Lemmon MA EMBO J; 2000 Sep; 19(17):4632-43. PubMed ID: 10970856 [TBL] [Abstract][Full Text] [Related]
39. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. Shelly M; Pinkas-Kramarski R; Guarino BC; Waterman H; Wang LM; Lyass L; Alimandi M; Kuo A; Bacus SS; Pierce JH; Andrews GC; Yarden Y J Biol Chem; 1998 Apr; 273(17):10496-505. PubMed ID: 9553109 [TBL] [Abstract][Full Text] [Related]
40. P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer. Montero JC; Seoane S; Ocaña A; Pandiella A Oncogene; 2011 Mar; 30(9):1059-71. PubMed ID: 21042280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]